Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Studio City International Holdings ( (MSC) ).
On September 16, 2025, Studio City International Holdings Limited announced that its subsidiary, SCRS, entered into an agreement with iRad to operate a private hospital at the Studio City integrated resort. The agreement, effective from January 1, 2025, allows iRad to provide imaging and diagnostic services starting tentatively on October 1, 2025, until November 30, 2034, with options for renewal. This strategic move is part of the company’s commitment to supporting Macau’s healthcare industry and aligns with its broader operational goals.
The most recent analyst rating on (MSC) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Studio City International Holdings stock, see the MSC Stock Forecast page.
Spark’s Take on MSC Stock
According to Spark, TipRanks’ AI Analyst, MSC is a Neutral.
The overall stock score reflects significant financial performance challenges, including negative profitability and high leverage. Technical indicators suggest weak momentum, and valuation metrics are unfavorable due to negative earnings. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on MSC stock, click here.
More about Studio City International Holdings
Studio City International Holdings Limited operates in the entertainment and hospitality industry, primarily focusing on integrated resort development. The company is involved in the gaming market and is linked with Melco Resorts & Entertainment Limited, a prominent player in the sector.
Average Trading Volume: 23,367
Technical Sentiment Signal: Sell
Current Market Cap: $834.4M
For detailed information about MSC stock, go to TipRanks’ Stock Analysis page.